{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:40:46Z","timestamp":1792978846409,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","award":["733\/31\/2020"],"award-info":[{"award-number":["733\/31\/2020"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","award":["733\/31\/2020"],"award-info":[{"award-number":["733\/31\/2020"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014438","name":"Business Finland","doi-asserted-by":"publisher","award":["733\/31\/2020"],"award-info":[{"award-number":["733\/31\/2020"]}],"id":[{"id":"10.13039\/501100014438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Alzheimer\u2019s disease (AD) is a major determinant of healthcare costs and increase in the healthcare service use occur already before the AD diagnosis. However, little is known how the different diagnosis categories contribute to this increase in healthcare use. We investigated how the hospitalizations and specialized healthcare outpatient visits from different diagnosis categories, based on the International Classification of Diseases (ICD-10) chapters, contribute to increased specialized healthcare service use during ten-year period preceding AD diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A register-based nationwide cohort of 42,934 community-dwelling persons who received clinically verified AD diagnosis in between 2008 and 2011 in Finland and 1:1 age, sex and hospital district- matched comparison cohort were included. Hospitalizations and specialized healthcare visits were categorized by the main diagnosis, according to the ICD-10 chapters. AD and dementia were separated to their own category. The number of persons with visits and stays was calculated for every 6 months, irrespective of the frequency of visits\/stays individual had during that time window. Furthermore, the relative distribution of the diagnosis categories was computed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>AD cohort was more likely to have visits and stays during the 10-year period (OR 1.19, 95% CI 1.17\u20131.21). The number of persons with visits and stays peaked in AD cohort from 1.5 years before the diagnosis when the differences in relative distribution of different diagnosis categories also became evident. The largest differences were observed for visits\/stays with cognitive disorders, symptoms of unspecified diseases and psychiatric disorders diagnoses, and those with missing diagnosis codes in the last time window before AD diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions and implications<\/jats:title>\n                <jats:p>Increased healthcare service use before AD diagnosis does not seem to arise from differences in specific diagnosis categories of ICD-10 such as diseases of the circulatory system, but from the higher frequency of visits and stays among persons with AD across diagnosis categories. Based on the relative distribution of diagnosis categories, the steep increase in healthcare service use just before and during the diagnostic process is likely due to prodromal symptoms and visits related to cognition.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-09345-3","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T17:25:52Z","timestamp":1680629152000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnostic groups of hospital stays and outpatient visits during 10 years before Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"23","author":[{"given":"Kiira","family":"M\u00e4klin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasi","family":"Lampela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartikainen","family":"Sirpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maija","family":"Tolppanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"9345_CR1","unstructured":"WorldHealth Organisation. Dementia: A Public Health Priority. Accessed June 21, 2022. https:\/\/www.who.int\/publications-detail-redirect\/dementia-a-public-health-priority"},{"key":"9345_CR2","first-page":"140349481561470","volume":"9","author":"H Taipale","year":"2015","unstructured":"Taipale H, Purhonen M, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S. Hospital care and drug costs from five years before until two years after the diagnosis of Alzheimer\u2019s disease in a finnish nationwide cohort. Scandinavian J Public Health. 2015;9:1403494815614705. [pii].","journal-title":"Scandinavian J Public Health"},{"issue":"3","key":"9345_CR3","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10198-018-1004-0","volume":"20","author":"E Sopina","year":"2019","unstructured":"Sopina E, Spackman E, Martikainen J, Waldemar G, Sorensen J. Long-term medical costs of Alzheimer\u2019s disease: matched cohort analysis. The Eur J health economics: HEPAC: health Econ Prev care. 2019;20(3):333\u201342. https:\/\/doi.org\/10.1007\/s10198-018-1004-0. [doi].","journal-title":"The Eur J health economics: HEPAC: health Econ Prev care"},{"issue":"5","key":"9345_CR4","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/alz.12237","volume":"17","author":"G Grande","year":"2021","unstructured":"Grande G, Marengoni A, Vetrano DL, et al. Multimorbidity burden and dementia risk in older adults: the role of inflammation and genetics. Alzheimer\u2019s & Dementia. 2021;17(5):768\u201376. https:\/\/doi.org\/10.1002\/alz.12237.","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"6","key":"9345_CR5","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1016\/S2666-7568(22)00117-9","volume":"3","author":"XY Tai","year":"2022","unstructured":"Tai XY, Veldsman M, Lyall DM, et al. Cardiometabolic multimorbidity, genetic risk, and dementia: a prospective cohort study. The Lancet Healthy Longevity. 2022;3(6):e428\u201336. https:\/\/doi.org\/10.1016\/S2666-7568(22)00117-9.","journal-title":"The Lancet Healthy Longevity"},{"key":"9345_CR6","doi-asserted-by":"publisher","first-page":"e068005","DOI":"10.1136\/bmj-2021-068005","volume":"376","author":"CB Hassen","year":"2022","unstructured":"Hassen CB, Fayosse A, Landr\u00e9 B, et al. Association between age at onset of multimorbidity and incidence of dementia: 30 year follow-up in Whitehall II prospective cohort study. BMJ. 2022;376:e068005. https:\/\/doi.org\/10.1136\/bmj-2021-068005.","journal-title":"BMJ"},{"issue":"1","key":"9345_CR7","doi-asserted-by":"publisher","first-page":"e0169650","DOI":"10.1371\/journal.pone.0169650","volume":"12","author":"Y Li","year":"2017","unstructured":"Li Y, Li Y, Li X, et al. Head Injury as a risk factor for Dementia and Alzheimer\u2019s Disease: a systematic review and Meta-analysis of 32 observational studies. PLoS ONE. 2017;12(1):e0169650. https:\/\/doi.org\/10.1371\/journal.pone.0169650.","journal-title":"PLoS ONE"},{"key":"9345_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.arr.2018.04.001","volume":"44","author":"GM Swords","year":"2018","unstructured":"Swords GM, Nguyen LT, Mudar RA, Llano DA. Auditory system dysfunction in Alzheimer disease and its prodromal states: a review. Ageing Res Rev. 2018;44:49\u201359. https:\/\/doi.org\/10.1016\/j.arr.2018.04.001.","journal-title":"Ageing Res Rev"},{"issue":"7","key":"9345_CR9","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/aos.14114","volume":"97","author":"XH Xu","year":"2019","unstructured":"Xu XH, Zou JY, Geng W, Wang AY. Association between glaucoma and the risk of Alzheimer\u2019s disease: a systematic review of observational studies. Acta Ophthalmol. 2019;97(7):665\u201371. https:\/\/doi.org\/10.1111\/aos.14114.","journal-title":"Acta Ophthalmol"},{"issue":"19","key":"9345_CR10","doi-asserted-by":"publisher","first-page":"4360","DOI":"10.3390\/jcm10194360","volume":"10","author":"I Avitan","year":"2021","unstructured":"Avitan I, Halperin Y, Saha T, et al. Towards a Consensus on Alzheimer\u2019s Disease Comorbidity? J Clin Med. 2021;10(19):4360. https:\/\/doi.org\/10.3390\/jcm10194360.","journal-title":"J Clin Med"},{"issue":"1","key":"9345_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13195-017-0283-5","volume":"9","author":"PS Aisen","year":"2017","unstructured":"Aisen PS, Cummings J, Jack CR, et al. On the path to 2025: understanding the Alzheimer\u2019s disease continuum. Alzheimer\u2019s Research & Therapy. 2017;9(1):60. https:\/\/doi.org\/10.1186\/s13195-017-0283-5.","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"9984","key":"9345_CR12","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet (London England). 2015;385(9984):2255\u201363. https:\/\/doi.org\/10.1016\/S0140-6736(15)60461-5. [doi].","journal-title":"Lancet (London England)"},{"issue":"8","key":"9345_CR13","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1097\/MLR.0b013e318178940b","volume":"46","author":"TC Kuo","year":"2008","unstructured":"Kuo TC, Zhao Y, Weir S, Kramer MS, Ash AS. Implications of comorbidity on costs for patients with Alzheimer disease. Med Care. 2008;46(8):839\u201346. https:\/\/doi.org\/10.1097\/MLR.0b013e318178940b. [doi].","journal-title":"Med Care"},{"issue":"7","key":"9345_CR14","first-page":"528","volume":"34","author":"H Fillit","year":"2002","unstructured":"Fillit H, Hill JW, Futterman R. Health care utilization and costs of Alzheimer\u2019s disease: the role of co-morbid conditions, disease stage, and pharmacotherapy. Fam Med. 2002;34(7):528\u201335.","journal-title":"Fam Med"},{"issue":"7","key":"9345_CR15","doi-asserted-by":"publisher","first-page":"e012100","DOI":"10.1136\/bmjopen-2016-012100","volume":"6","author":"AM Tolppanen","year":"2016","unstructured":"Tolppanen AM, Taipale H, Koponen M, et al. Cohort profile: the finnish medication and Alzheimer\u2019s disease (MEDALZ) study. BMJ open. 2016;6(7):e012100\u2013012100. https:\/\/doi.org\/10.1136\/bmjopen-2016-012100. [doi].","journal-title":"BMJ open"},{"issue":"7","key":"9345_CR16","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344.","journal-title":"Neurology"},{"key":"9345_CR17","unstructured":"American Psychiatric Association. Diagnostic and statistical Manual of Mental Disorders. 4th ed. American Psychiatric Association; 1994."},{"key":"9345_CR18","volume-title":"International Statistical classification of Diseases and related health problems 10th revision","author":"World Health Organisation","year":"2011","unstructured":"World Health Organisation. International Statistical classification of Diseases and related health problems 10th revision. Switzerland: Geneva; 2011."},{"issue":"7","key":"9345_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jalz.2019.04.001","volume":"15","author":"L Vermunt","year":"2019","unstructured":"Vermunt L, Sikkes SAM, van den Hout A, et al. Duration of Preclinical, Prodromal and Dementia Alzheimer Disease Stages in Relation to Age, Sex, and APOE genotype. Alzheimers Dement. 2019;15(7):888\u201398. https:\/\/doi.org\/10.1016\/j.jalz.2019.04.001.","journal-title":"Alzheimers Dement"},{"issue":"19","key":"9345_CR20","doi-asserted-by":"publisher","first-page":"4582","DOI":"10.3390\/jcm10194582","volume":"10","author":"T Rujeedawa","year":"2021","unstructured":"Rujeedawa T, Carrillo F\u00e9lez E, Clare ICH, et al. The clinical and neuropathological features of sporadic (Late-Onset) and genetic forms of Alzheimer\u2019s Disease. J Clin Med. 2021;10(19):4582. https:\/\/doi.org\/10.3390\/jcm10194582.","journal-title":"J Clin Med"},{"issue":"6","key":"9345_CR21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1007\/s43440-021-00293-5","volume":"73","author":"K Maciejewska","year":"2021","unstructured":"Maciejewska K, Czarnecka K, Szyma\u0144ski P. A review of the mechanisms underlying selected comorbidities in Alzheimer\u2019s disease. Pharmacol Rep. 2021;73(6):1565\u201381. https:\/\/doi.org\/10.1007\/s43440-021-00293-5.","journal-title":"Pharmacol Rep"},{"key":"9345_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.eurpsy.2017.02.486","volume":"43","author":"V Tapiainen","year":"2017","unstructured":"Tapiainen V, Hartikainen S, Taipale H, Tiihonen J, Tolppanen AM. Hospital-treated mental and behavioral disorders and risk of Alzheimer\u2019s disease: a nationwide nested case-control study. Eur psychiatry: J Association Eur Psychiatrists. 2017;43:92\u20138. doi:S0924-9338(17)32766-9 [pii].","journal-title":"Eur psychiatry: J Association Eur Psychiatrists"},{"key":"9345_CR23","unstructured":"The Ministry of Social Affairs and Health.Health services. https:\/\/stm.fi\/en\/health-services"},{"issue":"6","key":"9345_CR24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1177\/1403494812456637","volume":"40","author":"R Sund","year":"2012","unstructured":"Sund R. Quality of the Finnish Hospital Discharge Register: a systematic review. Scand J Public Health. 2012;40(6):505\u201315. https:\/\/doi.org\/10.1177\/1403494812456637. [doi].","journal-title":"Scand J Public Health"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09345-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09345-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,5]],"date-time":"2023-04-05T06:52:23Z","timestamp":1680677543000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09345-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9345"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09345-3","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"6 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Register maintainers have approved the MEDALZ study plan. Data were pseudonymized before submission to the research team and study participants were not contacted. Therefore, according to Finnish legislation (including Personal Data Act 23\/1999, Act on the Openness of Government Activities 621\/1999 and Act on the Secondary Use of Health and Social Data 552\/2019 (and previous Act on the National Healthcare registers, not official English translation as this is not available 556\/1989) the study has been granted an exemption from requiring ethics approval or informed consent. We confirm that all methods were carried out in accordance with relevant guidelines and regulations including the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SH has received lecture fee from Eisai. AMT acknowledges a research grant from Amgen, paid to the institution where she is employed (outside of the submitted work). KM, PL, JL have nothing to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"339"}}